How This Evidence Evolved
Diverticulitis Surgical Management
Evolving Indications for Antibiotics and Surgery in Acute and Recurrent Diverticulitis
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
GIQLI quality of life at 6 months — surgery 114.4 vs conservative 100.4 (p<0.0001)
GIQLI at 5 years: surgery 118.2 vs conservative 108.5 (mean difference 9.7, 95% CI 1.7-17.7); 26 (46%) of the conservative group ultimately required surgery
Follow-up studies, subgroup analyses, and real-world validation
GIQLI change from randomization to 6 months: surgery 11.76 vs conservative -0.2 points (difference 11.96, 95% CI 3.72-20.19; P=.005)
GIQLI at 4 years: surgery 115.3 vs conservative 109.8 (mean difference 5.54, 95% CI -2.98 to 14.06); recurrence 16% vs 92%
Ongoing diverticulitis at 1 year: observation 7.2% vs antibiotics 5.0% (P=0.062); recurrent 8.6% vs 9.6% (P=0.610); complicated 4.0% vs 2.1% (P=0.079); significance threshold P<0.025
Integration into clinical practice guidelines and recommendations
Selective antibiotics in immunocompetent mild uncomplicated diverticulitis; elective surgery individualized by severity, preferences and quality of life.
Individualize elective resection by severity, preferences, risks and benefits, not episode count; use selective antibiotics for immunocompetent mild uncomplicated disease.
Elective resection for symptomatic diverticular disease that negatively affects quality of life (strong recommendation; moderate evidence).
Current standard of care and ongoing research directions
Landmark Trials in This Story
Randomized clinical trial of observational versus antibiotic treatment for a first episode of CT-proven uncomplicated acute diverticulitis
Time to recovery — no significant difference: observational 14 days vs antibiotics 12 days; no difference in complicated diverticulitis (3.8% vs 2.6%)
Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled trial
GIQLI quality of life at 6 months — surgery 114.4 vs conservative 100.4 (p<0.0001)
Long-term Outcome of Surgery Versus Conservative Management for Recurrent and Ongoing Complaints After an Episode of Diverticulitis: 5-year Follow-up Results of a Multicenter Randomized Controlled Trial (DIRECT-Trial).
GIQLI at 5 years: surgery 118.2 vs conservative 108.5 (mean difference 9.7, 95% CI 1.7-17.7); 26 (46%) of the conservative group ultimately required surgery
Comparing Laparoscopic Elective Sigmoid Resection With Conservative Treatment in Improving Quality of Life of Patients With Diverticulitis: The Laparoscopic Elective Sigmoid Resection Following Diverticulitis (LASER) Randomized Clinical Trial
GIQLI change from randomization to 6 months: surgery 11.76 vs conservative -0.2 points (difference 11.96, 95% CI 3.72-20.19; P=.005)
Sigmoid Resection vs Conservative Treatment After Diverticulitis: Prespecified 4-Year Analysis of the LASER Randomized Clinical Trial.
GIQLI at 4 years: surgery 115.3 vs conservative 109.8 (mean difference 5.54, 95% CI -2.98 to 14.06); recurrence 16% vs 92%
Observational versus antibiotic treatment for uncomplicated diverticulitis: an individual-patient data meta-analysis.
Ongoing diverticulitis at 1 year: observation 7.2% vs antibiotics 5.0% (P=0.062); recurrent 8.6% vs 9.6% (P=0.610); complicated 4.0% vs 2.1% (P=0.079); significance threshold P<0.025
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.